Sung-Soo Park leads the BioDrone Research Center and is a specialist in cell and gene-based therapeutics with extensive global research experience.

He earned his degrees in chemical engineering and biotechnology from Seoul National University and completed postdoctoral research at the University of Pittsburgh and the NIH.

He later served as a senior researcher at the University of Michigan and held leadership roles at Helixmith, gaining deep expertise in both R&D and organizational management.

He now leads the advancement of precision drug delivery technologies at Carus Bio.